Sign In
Buy PFS
$23.51
-0.0200 (-0.0850%)
At Close: Jul 13, 2026
WHITE SULPHUR SPRINGS, Mont., July 09, 2026 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sandfire America" or the "Company") is pleased to announce the results of an updated Preliminary Feasi
Provident Financial Services, Inc. Schedules Second Quarter Earnings Conference Call
10:32am, Wednesday, 01'st Jul 2026
ISELIN, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended June 30, 2026 on Wednesday,
Tartisan Nickel Corp. Retains Tetra Tech to Complete PFS Gap Analysis for the Kenbridge Nickel-Copper Project, Northwestern Ontario
07:50am, Thursday, 25'th Jun 2026
Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - Tartisan Nickel Corp. (CSE: TN) (OTCQX: TTSRF) (FSE: 8TA) ("Tartisan", or the "Company") is pleased to announce that it has engaged Tetra Tech C
FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance
03:00pm, Wednesday, 24'th Jun 2026
Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCEÂ (palbociclib) in combination with trastuzumab, with or w
Today, American Ocean Minerals Corporation (AOMC) announced the successful completion of Expedition 7, a research campaign designed to support the environmenta
Provident Bank Appoints Adriano Duarte EVP and Chief Financial Officer
08:00am, Tuesday, 23'rd Jun 2026
ISELIN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of Adriano Duarte to Executive Vice President and Chie
AbbVie Announces European Commission Approval of SKYRIZIÂ (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaqu
Tunkillia Pre-Feasibility Study Begins
09:00pm, Sunday, 21'st Jun 2026
Expanded programs targeting Q1 CY27 completion & ML application HIGHLIGHTS GR Engineering appointed to lead Pre-feasibility Study (PFS) for Tunkillia Gold Project; targeting Q1 CY27 PFS completion to
Provident Bank Announces $1 Million in Grants to Ten New Jersey Non-Profit Organizations
08:00am, Wednesday, 17'th Jun 2026
Funds will be used to support revitalization plans for distressed neighborhoods Funds will be used to support revitalization plans for distressed neighborhoods
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited
[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously
New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
08:00am, Thursday, 11'th Jun 2026
[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 datas
REGN Investors Have Opportunity to Join Regeneron Pharmaceuticals, Inc. Fraud Investigation with the Schall Law Firm
04:00pm, Wednesday, 10'th Jun 2026
[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron P
